Free Trial

Oragenics (OGEN) SEC Filings & 10K Form

Oragenics logo
$0.36 -0.02 (-5.53%)
(As of 12/20/2024 05:45 PM ET)

Recent Oragenics SEC Filings

DateFilerForm TypeView
12/19/2024
9:00 AM
Oragenics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/16/2024
3:05 PM
Oragenics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/16/2024
3:10 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
5:07 PM
DUNTON ALAN W (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:23 PM
Oragenics (Issuer)
Telling Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:35 PM
Oragenics (Subject)
Telling Fred (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
1:04 PM
DUNTON ALAN W (Reporting)
Oragenics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
4:00 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:29 PM
Lind Global Fund II LP (Filed by)
Oragenics (Subject)
Form SC 13G/A
11/13/2024
1:40 PM
Oragenics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
8:20 AM
Oragenics (Filer)
Form DEFA14A
10/31/2024
8:15 AM
Oragenics (Filer)
Form DEF 14A
10/18/2024
7:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
9:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
5:25 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:45 PM
Oragenics (Filer)
Form 424B5
10/09/2024
6:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
8:15 PM
Oragenics (Issuer)
Telling Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
Murphy Kimberly M (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
Cassidy Bruce A. Sr. (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
KOSKI ROBERT C (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
DUNTON ALAN W (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
GANDOLFO JOHN P (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
Oragenics (Issuer)
POPE CHARLES L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
Oragenics (Issuer)
REDMOND J MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
Huffman Janet (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:45 AM
Iroquois Capital Management, LLC (Filed by)
Oragenics (Subject)
Form SC 13G
09/05/2024
3:45 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
7:26 AM
Oragenics (Filer)
Form 424B5
09/03/2024
11:15 PM
Oragenics (Filer)
Form EFFECT
08/21/2024
7:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:30 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:30 PM
Oragenics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
3:35 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:30 PM
Oragenics (Filer)
Form 424B5
06/20/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
8:27 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

05/22/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
12:00 PM
Oragenics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
7:14 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
7:01 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:16 PM
Oragenics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2024
6:38 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
3:24 PM
Lind Global Fund II LP (Filed by)
Oragenics (Subject)
Form SC 13G
03/01/2024
3:05 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
8:03 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
7:06 PM
Odyssey Health, Inc. (Filed by)
Oragenics (Subject)
Form SC 13D
02/07/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
4:18 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2024
4:30 PM
KOSKI ROBERT C (Reporting)
Oragenics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/16/2024
8:04 AM
Oragenics (Filer)
Form 424B5
01/16/2024
8:08 AM
Oragenics (Subject)
Form FWP
01/16/2024
8:10 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
3:37 PM
Oragenics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/02/2024
3:40 PM
Oragenics (Issuer)
REDMOND J MICHAEL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
8:22 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
6:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:OGEN) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners